220 related articles for article (PubMed ID: 24753215)
41. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
[TBL] [Abstract][Full Text] [Related]
42. Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification.
León X; López M; García J; Viza I; Gich I; Quer M
Head Neck; 2008 Jul; 30(7):939-45. PubMed ID: 18302258
[TBL] [Abstract][Full Text] [Related]
43. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
[TBL] [Abstract][Full Text] [Related]
44. [Multivariate survival analysis in patient with laryngeal squamous cell carcinomas].
Guo J; Chen F; Guan Z; Chen Y; Li Q; Ouyang D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):636-9. PubMed ID: 17017186
[TBL] [Abstract][Full Text] [Related]
45. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
[TBL] [Abstract][Full Text] [Related]
47. Indications for postoperative radiotherapy in laryngeal carcinoma: a panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study.
Marioni G; Blandamura S; Lionello M; Giacomelli L; Lovato A; Favaretto N; Breda S; Tealdo G; Guzzardo V; Ottaviano G; Staffieri A
Head Neck; 2014 Nov; 36(11):1534-40. PubMed ID: 23996283
[TBL] [Abstract][Full Text] [Related]
48. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
49. SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma.
Tang XB; Shen XH; Li L; Zhang YF; Chen GQ
Auris Nasus Larynx; 2013 Oct; 40(5):481-6. PubMed ID: 23462687
[TBL] [Abstract][Full Text] [Related]
50. Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma.
Hanada S; Kakehashi A; Nishiyama N; Wei M; Yamano S; Chung K; Komatsu H; Inoue H; Suehiro S; Wanibuchi H
Cancer Biomark; 2013; 13(4):289-98. PubMed ID: 24240590
[TBL] [Abstract][Full Text] [Related]
51. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
52. Postoperative radiotherapy for laryngeal carcinoma: the prognostic role of subcellular Maspin expression.
Lionello M; Blandamura S; Staffieri C; Tealdo G; Giacomelli L; Marchese Ragona R; de Filippis C; Staffieri A; Marioni G
Am J Otolaryngol; 2015; 36(2):184-9. PubMed ID: 25459315
[TBL] [Abstract][Full Text] [Related]
53. Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.
Yang JQ; Liang Z; Wu M; Sun YM; Liu HX
Int J Clin Exp Pathol; 2015; 8(5):5715-20. PubMed ID: 26191286
[TBL] [Abstract][Full Text] [Related]
54. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
[TBL] [Abstract][Full Text] [Related]
55. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
[TBL] [Abstract][Full Text] [Related]
57. Potential biomarkers for head and neck squamous cell carcinoma.
Brown JJ; Xu H; Nishitani J; Mohammed H; Osborne R; Teklehaimanot S; Gill G; Liu X
Laryngoscope; 2003 Mar; 113(3):393-400. PubMed ID: 12616185
[TBL] [Abstract][Full Text] [Related]
58. [Expression of IL-17 in laryngeal squamous cell carcinoma tissues and the clinical significance].
Wang Y; Yang J; Xu H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 27(14):779-83. PubMed ID: 24167997
[TBL] [Abstract][Full Text] [Related]
59. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
[TBL] [Abstract][Full Text] [Related]
60. Clinical and molecular prognostic factors in operable laryngeal cancer.
Vlachtsis K; Nikolaou A; Markou K; Fountzilas G; Daniilidis I
Eur Arch Otorhinolaryngol; 2005 Nov; 262(11):890-8. PubMed ID: 15739081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
